Vermillion's Q1 Revenues Drop 28 Percent; CEO Page to Leave Firm | GenomeWeb

NEW YORK (GenomeWeb News) – Vermillion reported after the close of the market on Tuesday that a drop in its product revenues led to a 28-percent decrease year over year in total revenues for the first quarter.

The company also announced that President and CEO Gail Page will be leaving the company by September and Vermillion has begun the process to find her successor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.